Development and Clinical Validation of a Novel 5 Gene Signature Based on Fatty Acid Metabolism-Related Genes in Oral Squamous Cell Carcinoma

Abstract

Background/Aim.Lipid metabolism disorders play a crucial role in tumor development and progression. The aim of the study focused on constructing a novel prognostic model of oral squamous cell carcinoma (OSCC) patients using fatty acid metabolism-related genes. Methods. Microarray test and data from The Cancer Genome Atlas (TCGA) were used to identify differentially expressed genes related to fatty acid metabolism. The quantitative real-time polymerase chain reaction (qRT-PCR) was then used to validate the expression of targeted fatty acid metabolism genes. A risk predictive scoring model of fatty acid metabolism-related genes was generated using a multivariate Cox model. The efficacy of this model was assessed by time-dependent receiver operating characteristic curve (ROC). Results. 14 fatty acid metabolism-related genes were identified by microarray test and TCGA database analysis and then confirmed by PCR. Finally, a 5 gene signature (ACACB, FABP3, PDK4, PPARG, and PLIN5) was constructed and a RiskScore was calculated for each patient. Compared to the high RiskScore group, the low RiskScore group had better overall survival (OS) ( p = 0.02 ). The RiskScore derived from a 5 gene signature was a prognostic factor (HR: 3.73, 95% CI: 1.38, 10.09) for OSCC patients. The predictive classification efficiencies of RiskScore were evaluated and the area under the curve (AUC) values for 1, 3, and 5 years were 0.613, 0.652, and 0.681, respectively. Then we compared the predictive performance of the prognostic model with or without the RiskScore. The 5 gene-derived RiskScore can improve the predictive performance with AUC values of 0.760, 0.803, and 0.830 for 1, 3, and 5 years OS in prognostic model including the RiskScore. While the predicted AUC values of the model without RiskScore for 1, 3, and 5 years OS were 0.699, 0.715, and 0.714, respectively. Conclusion. We developed a predictive score model using 5 fatty acid metabolism-related genes, which could be a potential prognostic indicator in OSCC.

Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity

“…Indeed, integrating the T‐cell metabolome with genome biomarker analyses to classify endogenous metabolic pathways may add a new dimension to prognostic predictions of tumour therapy. 11 , 213 Recently, a lipid metabolism gene prognostic signature was successfully validated for tumour patient survival, immune infiltration, cell mutation and treatment prognosis 214 , 215 and was also validated via scRNA‐seq‐based construct analysis for patients with hepatocellular carcinoma. 216 , 217 Furthermore, the effects of several metabolic pathways that have received less attention, such as selenium metabolism, 218 polyamine metabolism 219 and folate metabolism, 220 on tumour prognosis have been supported by preliminary validation data.…”

Landscape and the immune patterns of cuproptosis in oral squamous cell carcinoma

“…DSG‐3 overexpression is significantly associated with poor differentiation and metastasis in OSCC 22 . PPARG regulates fatty acid metabolism‐related genes in OSCC 23 . RYR2 mutations have been found in 23.3% of OSCC cases associated with tobacco consumption, 24 and the loss of RYR2 expression is responsible for malignant conversion 25 .…”

“…22 PPARG regulates fatty acid metabolism-related genes in OSCC. 23 RYR2 mutations have been found in 23.3% of OSCC cases associated with tobacco consumption, 24 and the loss of RYR2 expression is responsible for malignant conversion. 25 CD8+ cell infiltration is associated with improved OS and serves as an independent prognostic factor for OSCC.…”

A novel immune-related prognostic model with surgical status to predict tumor immune cell infiltration and drug sensitivity in head and neck squamous cell carcinoma

“…As a well-known tumor type with a strong immune infiltration response [ 11 ], immune-related signatures were used to predict the prognosis, immune checkpoint expression, TIC levels, and various response states after ICI treatment in HNSCC [ 12 , 13 ]. Immune-related signatures were more accurate in predicting OS than prediction models based on glycosyltransferase and fatty acid metabolism-related signatures [ 10 , 14 ]. Screening for further immune-related signatures and developing TIC prediction tools could improve outcome evaluation in HNSCC and lead to better clinical and therapeutic strategies.…”